Valion Bio (VBIO) Gross Margin Growth (1y) (2022 - 2026)
Powered by 
Analysis
Valion Bio (VBIO) Gross Margin Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 484.00 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 96.00 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -93.00 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -91.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 210.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 1,966.00 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -475.00 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -553.00 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -1,260.00 |
| 10 | Valion Bio | 298,792.01 | -1.90 Mn | -45,000.00 | -17,818.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17,818.00 |
| Dec 31, 2025 | 22,403.00 |
| Sep 30, 2025 | -13,424.00 |
| Jun 30, 2025 | 4,136.00 |
| Mar 31, 2025 | 2,143.00 |
| Dec 31, 2024 | -13,418.00 |
| Sep 30, 2024 | -338.00 |
| Jun 30, 2024 | -1,646.00 |
| Mar 31, 2024 | 1,995.00 |
| Dec 31, 2023 | -914.00 |
| Sep 30, 2023 | 2,509.00 |
| Jun 30, 2023 | 1,421.00 |
| Mar 31, 2023 | 1,370.00 |
| Dec 31, 2022 | 1,105.00 |
| Sep 30, 2022 | 2,259.00 |
| Jun 30, 2022 | 3,599.00 |
| Mar 31, 2022 | 954.00 |